Digitisation | December 19, 2025
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
The update promises to revolutionize laboratory workflows by optimizing resources
The update promises to revolutionize laboratory workflows by optimizing resources
GS-098, a first-in-class, humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor, is designed to rapidly block the pathogenic activity of thyroid-stimulating autoantibodies
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Subscribe To Our Newsletter & Stay Updated
